Efficacy and safety of immune checkpoint inhibitors for brain metastases of non-small cell lung cancer: a systematic review and network meta-analysis.

Front Oncol · 2025 · PMC12040931 · PMID 40308503

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may be significantno p-value reported

Notably, the BM patients included in this study originated from both SCLC and NSCLC, and there may be significant prognostic differences between patients with BMs from these different origins, which could influence the efficacy of ICI treatments.

also in 13,097 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.